Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market before cheaper generic versions hit shelves in March next year.

Seventy-eight percent of the stock screens AAII tracks posted gains during 2025, with an average gain of 14.7%.

Torrid Holdings Inc. remains a Sell as revenue, profits, and cash flows continue to deteriorate. Learn more about CURV stock ...

Though the bitcoin story stock has lost some of its luster lately, Saylor is gearing up to attract a new crop of investors that could help lift Strategy's shares.

In the MICE industry, we often measure success by precision, but the strength of your strategy is tested by how fast you ...

In some cases, businesses assumed they were no longer eligible. In others, the credits were simply overlooked amid day-to-day pressures.

Village Farms is evolving from a low-margin grower to a regulated cannabis infrastructure platform. Click here to read my ...

After a sharp run and stronger earnings, one fund decided to lock in gains, raising questions about how much upside Interface really has left at this point in the cycle.

As part of conversations between AI healthcare leaders on the podcast AI Amplified this year, a clear picture emerged of where artificial intelligence is genuinely transforming healthcare — and where ...

The growing field of data center developers are catering to the tech industry’s ravenous demand for computing power to build ...

Hampton, Virginia, is experimenting with things like rain gardens, marsh restoration, and oyster-seeded artificial reefs.

Trump allies thrived in Washington, Democrats found new voices, and Elon Musk's political gamble turned into a costly backlash.